SBC Medical Group Holdings Incorporated (SBC)

NASDAQ: SBC · USD

$5.45

+0.24 (+4.6%)· Recorded snapshot

Market cap	560.5M
Revenue (ttm)	175.2M
Net income (ttm)	49M
EPS (ttm)	$0.48
Shares out	102.8M
P/E (trailing)	11.4x
P/E (forward)	10.5x
Volume	153,151
Beta	0.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 175.2M
Net income (ttm): 49M
EPS (ttm): $0.48
P/E (trailing): 11.4x
P/E (forward): 10.5x
Market cap: 560.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAL	American Airlines Group Inc.	8.3B	—	0.1x	3.0%	+20.0%	-6.9%	持有
ADP	Automatic Data Processing, Inc.	113B	25.3x	5.1x	62.8%	+7.7%	+4.5%	持有
ALLE	Allegion plc	15.2B	22.5x	3.5x	19.4%	+8.8%	+7.2%	持有

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E10.5

P25 n/aP50 n/aP75 n/a

Trailing P/E11.4

P25 n/aP50 n/aP75 n/a

ROE18.9

P25 n/aP50 n/aP75 n/a

ROIC29

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SBC indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

USD

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001930313
Company name	SBC Medical Group Holdings Incorporated
Country	United States
Country code	US
CUSIP number	73245B107
Earnings date	2026-11-13
Earnings time	bmo
Employees	863
Employees change	-776
Employees growth	-47.35%
Enterprise value	$424.1M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2000
In index	RUSSELL2000
Industry	Consulting Services
Is primary listing	Yes
Is SPAC	No
ISIN number	US73245B1070
Last 10-K release date	2026-03-27
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$560.5M
Market cap category	Small-Cap
Next earnings date	2026-11-13
Options	Yes
Price	$5.45
Price currency	USD
Sector	Industrials
SIC code	8011
Stock price date	2026-10-28
Symbol	SBC
U.S. state	California
Website	https://sbc-holdings.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	11.6x
Average P/E ratio (3Y)	9.36x
Earnings yield	8.77%
EV/Earnings	8.59x
EV/EBIT	6.44x
EV/EBITDA	6.13x
EV/FCF	6.94x
EV/Sales	2.4x
FCF / EV yield	14.42%
FCF yield	10.89%
Forward EV/Sales	2.12x
Forward P/E	10.47x
Forward P/S	2.81x
Graham number	5.25888
Graham upside	-2.97%
Industry forward P/E	18.25x
Industry P/E	24.65x
P/(FCF - SBC) ratio	9.18x
P/(OCF - SBC) ratio	8.87x
P/B ratio	2.03x
P/E ratio	11.4x
P/FCF ratio	9.18x
P/OCF ratio	8.87x
P/S ratio	3.18x
PEG ratio	2.09x
Price / tangible book value	2.75x
Price/EBITDA ratio	8.12x
Sector forward P/E	26.03x
Sector P/E	40.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	37.34%
EBITDA margin	39.18%
Effective tax rate	33.79%
FCF margin	34.65%
Gross margin	71.85%
Operating margin	37.34%
Pretax margin	42.77%
Profit margin	27.99%
Profit per employee	$56,809
Profitable quarters	15
Profitable years	4
Revenue per employee	$202,976
ROA	11.33%
ROCE	19.93%
ROE	18.91%
ROIC	29.05%
SBC / revenue	0%
Tax / revenue	14.45%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	45.03%
EPS growth (Q)	338.93%
EPS growth (QoQ)	-5.44%
EPS growth quarters	1
EPS growth years	2
FCF growth (QoQ)	153.88%
Gross profit growth	-13.11%
Gross profit growth (Q)	19.88%
Net income growth	47.08%
Net income growth (Q)	334.98%
Net income growth (QoQ)	-5.44%
Net income growth quarters	1
Net income growth years	3
OCF growth (QoQ)	143.82%
Operating income growth	-9.61%
Operating income growth (Q)	30.28%
Revenue growth	-6.92%
Revenue growth (Q)	13.44%
Revenue growth (QoQ)	14.23%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-2.1M
Depreciation and amortization	$3.2M
EBIT	$65.4M
EBITDA	$68.6M
EPS	$0.48
FCF per share	$0.59
Financing cash flow	$27.6M
Free cash flow	$60.7M
Free cash flow minus SBC	$60.7M
Gross profit	$125.9M
Income taxes	$25.3M
Investing cash flow	$-36.3M
Net borrowing	$29.5M
Net cash flow	$31.6M
Net income	$49M
Operating cash flow minus SBC	$62.8M
Operating income	$65.4M
Revenue	$175.2M
Stock-based compensation	$7,854

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.33
Book value per share	$2.57
Debt / EBITDA	0.65
Debt / equity	0.17
Debt / FCF	0.79
Goodwill	$15.2M
Interest coverage	187.88
Long-term assets	$147.3M
Long-term liabilities	$48.3M
Net cash (debt)	$136.4M
Net cash / market cap	24.47%
Net cash growth	-0.6%
Net debt / EBITDA	-1.99
Net debt / equity	-0.49
Net debt / FCF	-2.25
Piotroski F-Score	4
Property, plant and equipment	$17.9M
Shareholders' equity	$279.9M
Tangible book value	$203M
Tangible book value per share	$1.98
Total assets	$406.7M
Total cash	$184.6M
Total debt	$48.2M
Total liabilities	$126.7M
WACC	6.75%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.49
Current assets	$259.4M
Current liabilities	$78.5M
Current ratio	3.31
Inventory turnover	21.05
Net working capital	$13.6M
Quick ratio	3.19
Working capital	$180.9M
Working capital turnover	0.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.41%
Dividend yield	0%
Shareholder yield	-1.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$3.82
1D price change	4.61%
1M price change	10%
1M total return	10%
1W price change	-1.28%
1W total return	-1.28%
1Y price change	45.28%
1Y return CAGR	45.32%
1Y total return	45.28%
20-day SMA	$5.33
200-day SMA	$3.90
3M price change	68.97%
3M total return	68.97%
3Y price change	-49.58%
3Y return CAGR	-20.4%
3Y total return	-49.58%
50-day SMA	$4.80
50-day SMA vs 200-day SMA	50over200
52-week high	$5.79
52-week high date	2026-10-23
52-week low	$2.78
52-week low date	2026-05-19
6M price change	59.47%
6M total return	59.47%
All-time high	$36.52
All-time high date	2024-05-31
All-time low	$2.62
All-time low date	2025-03-06
Average true range (ATR)	$0.25
Average volume	186.5K
Beta (1Y)	0.2
Beta (2Y)	0.45
Beta (5Y)	0.55
Change from 52-week high	-5.92%
Change from 52-week low	96.04%
Change from all-time high	-85.24%
Change from all-time low	105.73%
Change from open	5.21%
Day's gap	-0.58%
Dollar volume	$834,673
High price	$5.48
Low price	$5.18
Monthly RSI	50.97
Open price	$5.18
Position in 52-week range	90%
Premarket change	-0.96%
Premarket close	$5.21
Premarket price	$5.16
Previous close	$5.21
Price vs 150-day SMA	41.17%
Price vs 20-day SMA	1.09%
Price vs 200-day SMA	38.21%
Price vs 50-day SMA	12.34%
Relative volume	0.82
RSI	56.79
Sharpe ratio	0.88
Sharpe ratio (3Y)	0.06
Sortino ratio	1.45
Sortino ratio (3Y)	0.15
Volume	153.2K
Weekly RSI	70.51
YTD price change	25.06%
YTD total return	25.06%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18.1M
Float percentage	17.6%
Shares change (QoQ)	0%
Shares change (YoY)	1.41%
Shares held by insiders	82.37%
Shares held by institutions	4.42%
Shares outstanding	102.8M
Short % of float	4.15%
Short % of shares	0.73%
Short ratio	3.8 days

Deeper analysis on SBC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SBC report

Is a complete SBC research report available?

No complete published report is available for SBC Medical Group Holdings Incorporated (SBC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SBC Medical Group Holdings Incorporated (SBC)

Price

Financial snapshot

Fair-value bridge

Latest news · SBC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SBC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SBC

Frequently asked questions